Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B3UJ
|
|||
| Former ID |
DIB004838
|
|||
| Drug Name |
Paliperidone
|
|||
| Synonyms |
Xeplion; Invega Sustenna; Paliperidone palmitate; JNS-010; Paliperidone (depot injection, NanoCrystal); Paliperidone (injectable, NanoCrystal), Elan; Paliperidone (depot injection, NanoCrystal), Johnson & Johnson
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Approved | [1], [2], [3] | |
| Company |
Johnson & Johnson
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H27FN4O3
|
|||
| Canonical SMILES |
CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
|
|||
| InChI |
1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3
|
|||
| InChIKey |
PMXMIIMHBWHSKN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 144598-75-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10236700, 14905143, 22395187, 29296762, 46506296, 47207025, 50035150, 51002222, 57339070, 85229944, 85246150, 90341688, 92719038, 92729808, 103604037, 103910909, 104105311, 104397925, 118046559, 121361150, 125307525, 125341102, 126584511, 126621140, 126649064, 126650388, 126667060, 128939139, 131465791, 131549340, 134338126, 135072932, 136367845, 137166111, 142528484, 144116334, 152258953, 152344196, 160647798, 160810375, 160964597, 162185890, 163088563, 163371020, 163564516, 163981461, 164175255, 164785605, 170501956, 171063034
|
|||
| ChEBI ID |
CHEBI:83804
|
|||
| ADReCS Drug ID | BADD_D01656 ; BADD_D01657 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | 5-HT receptor (5HTR) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7258). | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | ClinicalTrials.gov (NCT02146547) European Long-acting Antipsychotics in Schizophrenia Trial. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.